Spinal cord stimulation in XXXX and in @entity12761 .

@entity1 @entity602 @entity158 @entity14000 @entity12761 @entity1118
We studied the effects of @entity602 ( @entity602 ) on @entity14000 ( @entity14000 ). Data of 28 @entity1 were prospectively investigated over a median period of 29 (quartiles 9--39) mo. In addition, four @entity1 with @entity12761 were studied simultaneously. After intractable @entity158 for more than 2 yr, long-term @entity158 relief was achieved in 23 (82%) @entity14000 @entity1 (median, 70 yr) during @entity602 treatment confirmed by a median decrease from 9 to 1 on the visual analog scale (P < 0.001). In five cases with serious comorbidity, the initial @entity158 alleviation could not be stabilized. Spontaneous improvement was always confirmed or excluded by @entity602 inactivation tests at quarterly intervals. Eight @entity1 discontinued @entity602 permanently because of complete @entity158 relief after stimulation periods of 3--66 mo, whereas 2 reestablished @entity602 because of recrudescence after 2 and 6 mo. Considerable impairments in everyday life, objectified by the @entity158 disability index, were also significantly improved (P < 0.001). In 4 @entity1 with acute @entity158 , @entity602 was promptly effective and after periods of 2.5 (quartiles 2--3) months the @entity158 had subsided. @entity602 seems to offer a therapeutic option for pharmacological nonresponders. IMPLICATIONS: In many @entity1 with @entity14000 and @entity12761 is not satisfactorily alleviated with pharmacological approaches. We report on 23 of 28 @entity1 with @entity14000 and 4 of 4 with acute herpes zoster whose @entity1118 was improved by electrical @entity602 .
